Skip to main content

Table 1 Baseline characteristics

From: Antipsychotic adherence patterns and health care utilization and costs among patients discharged after a schizophrenia-related hospitalization

Characteristic All patients
Total Sample 2,541 100.00
Gender, n (%)   
  Male 1,440 56.67
  Female 1,101 43.33
Age at Index Admission Datea   
  Mean (SD) yrs. 41.17 12.18
  Age distribution (years), n (%)   
   18-24 315 12.40
   25-34 493 19.40
   35-44 578 22.75
   45-54 763 30.03
   55-64 392 15.43
Race/Ethnicity, n (%)   
  White 807 31.76
  Black 1,509 59.39
  Hispanic 16 0.63
  Other 209 8.23
Health Coverage, n (%)   
  Fee-for-service 1,557 61.28
  Capitated 984 38.72
Basis of Medicaid Eligibility, n (%)   
  Blind/disabled individual 2,393 94.18
  Adult (not based on unemployed status) 69 2.72
  Child (not child of unemployed adult, not foster care child) 65 2.56
  Otherb 14 0.55
Hospital Discharge Status, n (%)   
  Discharged to home self-care 2,254 88.71
  Transfer to skilled nursing facility 47 1.85
  Transfer to other facility 122 4.80
  Left against medical advice 14 0.55
  Other alive status 1 0.04
  Not yet discharged/transferred 26 1.02
  Missing/unknown 77 3.03
Preindex Periodc All-Cause Health Care Costs   
  Mean (SD) $8,162.64 $10,793.97
Preindex Period Depot Antipsychotic Used, n (%)   
Yes 126 4.96
No 2,415 95.04
Preindex Period Charlson Comorbidity Index Score   
  Mean (SD) 0.87 1.56
  1. SD standard deviation.
  2. aThe date for the first observed schizophrenia-related inpatient admission defined the index admission date.
  3. bOther included foster-care child, aged individual, and eligibility status unknown.
  4. cThe 6-month period prior to the index admission date defined the preindex period.
  5. dDefined as at least 1 claim for depot antipsychotic preparation, including risperidone, fluphenazine, and haloperidol.